Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koichi Yamamoto

Showing results (21-30 of 222) with videos related to

Pageof 23
Sort By:
Acta Oto-Laryngologica|September 11, 2002
Three-dimensional analysis of human locomotion in normal subjects and patients with vestibular deficiencyYoshinori Mamoto, Koichi Yamamoto, Takao Imai, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|March 18, 2026
Efficacy and Safety of Sacubitril/Valsartan After Switching From Azilsartan in Essential Hypertensive Patients: Based on Home Blood Pressure MonitoringYoshio Iwashima, Masato Sugiura, Takeshi Horio, et al.
STAR Protocols|May 5, 2022
A live-imaging protocol for tracking receptor dynamics in single cellsYibin Huang, Toshimasa Takahashi, Herbert Gaisano, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 17, 2025
Ikigai in aging hearts: Japan's approach to cardiovascular careRyo Nakamaru, Akitoshi Hara, Yuji Yamada, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|February 14, 2023
Is the anti-aging effect of ACE2 due to its role in the renin-angiotensin system?-Findings from a comparison of the aging phenotypes of ACE2-deficient, Tsukuba hypertensive, and Mas-deficient miceHikari Takeshita, Koichi Yamamoto, Masaki Mogi, et al.
Hypertension (Dallas, Tex. : 1979)|October 14, 2009
Telmisartan-induced inhibition of vascular cell proliferation beyond angiotensin receptor blockade and peroxisome proliferator-activated receptor-gamma activationKoichi Yamamoto, Mitsuru Ohishi, Christopher Ho, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|July 21, 2025
Adipose Composition Before and After Primary Aldosteronism Treatment Depends on Primary Aldosteronism Subtypes and Plasma Aldosterone Concentration Before the TreatmentEriko Nakano, Kosuke Mukai, Koichi Yamamoto, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|December 20, 2019
Different effects of the deletion of angiotensin converting enzyme 2 and chronic activation of the renin-angiotensin system on muscle weakness in middle-aged miceHikari Takeshita, Koichi Yamamoto, Masaki Mogi, et al.
Protein Science : a Publication of the Protein Society|November 2, 2023
Conformational features and interaction mechanisms of V<sub>H</sub> H antibodies with β-hairpin CDR3: A case of Nb8-HigB2 interactionKoichi Yamamoto, Satoru Nagatoishi, Ryo Matsunaga, et al.
Protein Science : a Publication of the Protein Society|March 18, 2025
Affinity-stability trade-off mechanism of residue 35 in framework region 2 of V<sub>H</sub>H antibodies with β-hairpin CDR3Koichi Yamamoto, Satoru Nagatoishi, Ryo Matsunaga, et al.
Pageof 23

Showing results (21-30 of 222) with videos related to

Sort By:
Pageof 23
Acta Oto-Laryngologica|September 11, 2002
Three-dimensional analysis of human locomotion in normal subjects and patients with vestibular deficiencyYoshinori Mamoto, Koichi Yamamoto, Takao Imai, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|March 18, 2026
Efficacy and Safety of Sacubitril/Valsartan After Switching From Azilsartan in Essential Hypertensive Patients: Based on Home Blood Pressure MonitoringYoshio Iwashima, Masato Sugiura, Takeshi Horio, et al.
STAR Protocols|May 5, 2022
A live-imaging protocol for tracking receptor dynamics in single cellsYibin Huang, Toshimasa Takahashi, Herbert Gaisano, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 17, 2025
Ikigai in aging hearts: Japan's approach to cardiovascular careRyo Nakamaru, Akitoshi Hara, Yuji Yamada, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|February 14, 2023
Is the anti-aging effect of ACE2 due to its role in the renin-angiotensin system?-Findings from a comparison of the aging phenotypes of ACE2-deficient, Tsukuba hypertensive, and Mas-deficient miceHikari Takeshita, Koichi Yamamoto, Masaki Mogi, et al.
Hypertension (Dallas, Tex. : 1979)|October 14, 2009
Telmisartan-induced inhibition of vascular cell proliferation beyond angiotensin receptor blockade and peroxisome proliferator-activated receptor-gamma activationKoichi Yamamoto, Mitsuru Ohishi, Christopher Ho, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|July 21, 2025
Adipose Composition Before and After Primary Aldosteronism Treatment Depends on Primary Aldosteronism Subtypes and Plasma Aldosterone Concentration Before the TreatmentEriko Nakano, Kosuke Mukai, Koichi Yamamoto, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|December 20, 2019
Different effects of the deletion of angiotensin converting enzyme 2 and chronic activation of the renin-angiotensin system on muscle weakness in middle-aged miceHikari Takeshita, Koichi Yamamoto, Masaki Mogi, et al.
Protein Science : a Publication of the Protein Society|November 2, 2023
Conformational features and interaction mechanisms of V<sub>H</sub> H antibodies with β-hairpin CDR3: A case of Nb8-HigB2 interactionKoichi Yamamoto, Satoru Nagatoishi, Ryo Matsunaga, et al.
Protein Science : a Publication of the Protein Society|March 18, 2025
Affinity-stability trade-off mechanism of residue 35 in framework region 2 of V<sub>H</sub>H antibodies with β-hairpin CDR3Koichi Yamamoto, Satoru Nagatoishi, Ryo Matsunaga, et al.
Pageof 23